Arena Pharmaceuticals, Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Arena Pharmaceuticals with three other
companies in this sector in the United States:
sales of $18.56 million
of which 100%
was research, development and manufacturing ),
Strongbridge Biopharma plc
of which 93%
was Keveyis), and
During the year ended December of 2018, sales at
Arena Pharmaceuticals were $17.97 million.
decrease of 15.8%
versus 2017, when the company's sales were $21.34 million.